Press Releases Latest Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders Press Releases Year None202420232022202120202019201820172016201520142013 Oct 01, 2015 Theratechnologies Announces Financial Results for Third Quarter of 2015 Sep 01, 2015 Theratechnologies Announces Commercialization Agreement for Tesamorelin in South Korea Aug 06, 2015 Theratechnologies Closes its Offering of Units Jul 31, 2015 Theratechnologies Announces the Exercise of the Over-Allotment Option Jul 30, 2015 Theratechnologies Announces The Filing of a Final Short Form Prospectus (ccn) Jul 24, 2015 Theratechnologies Announces $9,600,000 Firm Offering of Units and Filing of Preliminary Short Form Prospectus Jul 14, 2015 Theratechnologies Announces Financial Results for Second Quarter of 2015 Jul 14, 2015 EGRIFTA™ (Tesamorelin for Injection) Approved in Mexico Jun 25, 2015 Theratechnologies Initiates Canadian Distribution of EGRIFTA™ (Tesamorelin for Injection) Jun 09, 2015 Tesamorelin to be Assessed in the Treatment of Liver Disease in HIV-Infected Patients First page « Previous page ‹ … Page 27 Page 28 Page 29 Page 30 Current page 31 Page 32 Page 33 Page 34 Page 35 … Next page › Last page » Displaying 301 - 310 of 360
Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
Jul 24, 2015 Theratechnologies Announces $9,600,000 Firm Offering of Units and Filing of Preliminary Short Form Prospectus
Jun 25, 2015 Theratechnologies Initiates Canadian Distribution of EGRIFTA™ (Tesamorelin for Injection)